Magda Machado de Miranda Costa
Magda Machado de Miranda Costa has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Arnaldo Lopes Colombo
Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo , São Paulo
2 shared publications - Elaine Cristina Francisco
Special Mycology Laboratory, Division of Infectious Diseases, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil
2 shared publications - Felicidade Mota Pereira
Secretaria de Saúde do Estado da Bahia, Laboratório Central do Estado da Bahia, Salvador, BA, Brasil
2 shared publications - Ferry Hagen
Department of Medical Microbiology, University Medical Center Utrecht
2 shared publications - Igor B. Brandão
Comissão de Controle de Infecção Hospitalar, Hospital de Bahia, Salvador, Brazil
2 shared publications - Pedro H. Presta Dias
Centro de Informações Estratégicas de Vigilância em Saúde da Bahia, Salvador, Brazil
2 shared publications
Latest Publications
- Open Access
- 6 May 2025
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 17 (5) , e8329
Ações para o aprimoramento da gestão e uso de antimicrobianos em hospitais brasileiros com unidade de terapia intensiva adulto
Os Programas de Administração de Antimicrobianos (PGA) são ferramentas indispensáveis nos sistemas de saúde, promovendo o uso criterioso de antimicrobianos, reduzindo custos, internações e infecções por microrganismos resistentes, além de melhorar a segurança do paciente. Esse estudo apresentou como objetivo analisar as ações para o aprimoramento do uso de antimicrobianos implementadas pelos PGAs em Unidades de Terapia Intensiva (UTI) adulto de instituições hospitalares brasileiras. O estudo é de caráter transversal, prospectivo e multicêntrico. A coleta de dados foi realizada entre outubro de 2022 e janeiro de 2023, utilizando uma ferramenta eletrônica de autoavaliação de PGA previamente validada e disponibilizada no portal oficial da Agência Nacional de Viigilância Sanitária. Os critérios de avaliação das instituições com PGA foram organizados em seis componentes essenciais para a implementação desses programas. A presente pesquisa abordou especificamente os dados referentes ao Componente 4 - Ações para melhorar o uso de antimicrobianos, e compreendeu questões relacionadas a políticas, protocolos clínicos, ações estratégicas e complementares realizadas no gerenciamento de antimicrobianos em hospitais. O número de instituições brasileiras que completaram a autoavaliação foi de 1.170, das quais 594 (50,8%) informaram ter o PGA implementado. A análise das ações para o aprimoramento do uso de antimicrobianos em hospitais com UTI adulto, conduzidas por PGAs, evidenciou avanços importantes. Entretanto, há um grande potencial para melhorar a colaboração interdisciplinar, a comunicação com os prescritores e a implementação de sistemas mais robustos de controle e restrição do uso de antimicrobianos.
- 6 May 2025
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 17 (5) , e8329
Open AccessAções para o aprimoramento da gestão e uso de antimicrobianos em hospitais brasileiros com unidade de terapia intensiva adulto
Os Programas de Administração de Antimicrobianos (PGA) são ferramentas indispensáveis nos sistemas de saúde, promovendo o uso criterioso de antimicrobianos, reduzindo custos, internações e infecções por microrganismos resistentes, além de melhorar a segurança do paciente. Esse estudo apresentou como objetivo analisar as ações para o aprimoramento do uso de antimicrobianos implementadas pelos PGAs em Unidades de Terapia Intensiva (UTI) adulto de instituições hospitalares brasileiras. O estudo é de caráter transversal, prospectivo e multicêntrico. A coleta de dados foi realizada entre outubro de 2022 e janeiro de 2023, utilizando uma ferramenta eletrônica de autoavaliação de PGA previamente validada e disponibilizada no portal oficial da Agência Nacional de Viigilância Sanitária. Os critérios de avaliação das instituições com PGA foram organizados em seis componentes essenciais para a implementação desses programas. A presente pesquisa abordou especificamente os dados referentes ao Componente 4 - Ações para melhorar o uso de antimicrobianos, e compreendeu questões relacionadas a políticas, protocolos clínicos, ações estratégicas e complementares realizadas no gerenciamento de antimicrobianos em hospitais. O número de instituições brasileiras que completaram a autoavaliação foi de 1.170, das quais 594 (50,8%) informaram ter o PGA implementado. A análise das ações para o aprimoramento do uso de antimicrobianos em hospitais com UTI adulto, conduzidas por PGAs, evidenciou avanços importantes. Entretanto, há um grande potencial para melhorar a colaboração interdisciplinar, a comunicação com os prescritores e a implementação de sistemas mais robustos de controle e restrição do uso de antimicrobianos.
- Open Access
- 11 January 2022
- Published by Springer Nature in Research Square
Implementation of Evidence-Based Patient Safety Practices: 4-Years’ Follow-up of a Nationwide Regulatory Intervention in Brazilian Hospitals
Background: Regulatory interventions are widely recommended to improve the quality of health services, but there are few studies on the possible models and their effects. The aim of this study is to describe the implementation process and analyse the results of a nationwide regulatory intervention for the implementation of patient safety practices.Methods: Four nationwide annual cross-sectional assessments were conducted in Brazilian hospitals with Intensive Care Unit beds. The participants involved all facilities operating during 2016-2019 (average N=1,989). The regulatory intervention theory aimed to increase adherence to safe evidence-based practices through national annual assessment involving a set of 21 validated structure and process indicators related to patient safety practices. At moment 1(Risk assessment), data were collected to classify hospitals according to the risk. In the sequence, the Sanitary Surveillance Centers (VISAS) carried out the analysis of the information sent by the hospitals. VISAS classified services into three groups according to compliance with the composite adherence indicator: High (67-100%); Medium (34-66%); and Low Compliance (0-33%). Moment 2 (Risk management) used responsive actions according to the hospital’s classification. Results: The intervention resulted in six annual cyclic stages and, between 2016-2019, 782 (40.1%), 980 (49.0%), 1,093 (54.3%) and 1,255 (61.8%) hospitals participated, respectively. 17 of the 20 indicators with at least two measurements had a significant improvement after national interventions (pConclusion: The regulatory intervention used was a good tool to strengthen the information system and government actions to promote patient safety. The set of low-cost interventions seems to be useful to prioritise hospitals at higher risk and to induce responsive measures to implement patient safety practices in the evaluated context, promoting the efficiency of the regulatory process.
- 11 January 2022
- Published by Springer Nature in Research Square
Open AccessImplementation of Evidence-Based Patient Safety Practices: 4-Years’ Follow-up of a Nationwide Regulatory Intervention in Brazilian Hospitals
Background: Regulatory interventions are widely recommended to improve the quality of health services, but there are few studies on the possible models and their effects. The aim of this study is to describe the implementation process and analyse the results of a nationwide regulatory intervention for the implementation of patient safety practices.Methods: Four nationwide annual cross-sectional assessments were conducted in Brazilian hospitals with Intensive Care Unit beds. The participants involved all facilities operating during 2016-2019 (average N=1,989). The regulatory intervention theory aimed to increase adherence to safe evidence-based practices through national annual assessment involving a set of 21 validated structure and process indicators related to patient safety practices. At moment 1(Risk assessment), data were collected to classify hospitals according to the risk. In the sequence, the Sanitary Surveillance Centers (VISAS) carried out the analysis of the information sent by the hospitals. VISAS classified services into three groups according to compliance with the composite adherence indicator: High (67-100%); Medium (34-66%); and Low Compliance (0-33%). Moment 2 (Risk management) used responsive actions according to the hospital’s classification. Results: The intervention resulted in six annual cyclic stages and, between 2016-2019, 782 (40.1%), 980 (49.0%), 1,093 (54.3%) and 1,255 (61.8%) hospitals participated, respectively. 17 of the 20 indicators with at least two measurements had a significant improvement after national interventions (pConclusion: The regulatory intervention used was a good tool to strengthen the information system and government actions to promote patient safety. The set of low-cost interventions seems to be useful to prioritise hospitals at higher risk and to induce responsive measures to implement patient safety practices in the evaluated context, promoting the efficiency of the regulatory process.
- Open Access
- 20 October 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (6) , 883-887
Nanopore Genome Sequencing and Variant Analysis of the Susceptible Candida auris Strain L1537/2020, Salvador, Brazil
Candida auris has been reported worldwide, but only in December 2020, the first strain from a COVID-19 patient in Brazil was isolated. Here, we describe the genome sequence of this susceptible C. auris strain and performed variant analysis of the genetic relatedness with strains from other geographic localities.
- 20 October 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (6) , 883-887
Open AccessNanopore Genome Sequencing and Variant Analysis of the Susceptible Candida auris Strain L1537/2020, Salvador, Brazil
Candida auris has been reported worldwide, but only in December 2020, the first strain from a COVID-19 patient in Brazil was isolated. Here, we describe the genome sequence of this susceptible C. auris strain and performed variant analysis of the genetic relatedness with strains from other geographic localities.
- Open Access
- 17 March 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (3) , 220
Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit
In December 2020, Candida auris emerged in Brazil in the city of Salvador. The first two C. auris colonized patients were in the same COVID-19 intensive care unit. Antifungal susceptibility testing showed low minimal inhibitory concentrations of 1 µg/mL, 2 µg/mL, 0.03 µg/L, and 0.06 µg/mL for amphotericin B, fluconazole, voriconazole, and anidulafungin, respectively. Microsatellite typing revealed that the strains are clonal and belong to the South Asian clade C. auris. The travel restrictions during the COVID-19 pandemic and the absence of travel history among the colonized patients lead to the hypothesis that this species was introduced several months before the recognition of the first case and/or emerged locally in the coastline Salvador area.
- 17 March 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (3) , 220
Open AccessEmergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit
In December 2020, Candida auris emerged in Brazil in the city of Salvador. The first two C. auris colonized patients were in the same COVID-19 intensive care unit. Antifungal susceptibility testing showed low minimal inhibitory concentrations of 1 µg/mL, 2 µg/mL, 0.03 µg/L, and 0.06 µg/mL for amphotericin B, fluconazole, voriconazole, and anidulafungin, respectively. Microsatellite typing revealed that the strains are clonal and belong to the South Asian clade C. auris. The travel restrictions during the COVID-19 pandemic and the absence of travel history among the colonized patients lead to the hypothesis that this species was introduced several months before the recognition of the first case and/or emerged locally in the coastline Salvador area.